MENU

Akebia Therapeutics (AKBA) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

AKBA is expected to report earnings to fall 55.56% to -3 cents per share on August 01

Akebia Therapeutics AKBA Stock Earnings Reports
Q2'24
Est.
$-0.04
Q1'24
Missed
by $0.02
Q4'23
Beat
by $0.04
Q3'23
Est.
$-0.08
Q2'23
Missed
by $0.03
The last earnings report on May 09 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 2.83M shares outstanding, the current market capitalization sits at 308.11M.
View a ticker or compare two or three
AKBA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs for the treatment of anemia and vascular diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com